AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-86165754/novartis-launches-arthritis-drug.html" title="Facts and information about Novartis launches arthritis drug trial.(Brief Article)">Novartis launches arthritis drug trial.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
Novartis launches arthritis drug trial.(Brief Article)
M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD
The Swiss pharmaceutical group Novartis AG has launched a study aimed at evaluating the safety, tolerability and efficacy of its Prexige arthritis and pain treatment compared with the non-steroidal anti-inflammatory drugs ibuprofen and nanproxen.
The twelve-month study, called TARGET (Therapeutic Arthritis Research and Gastrointestinal Event Trial), will evaluate more than 18,000 patients worldwide. The …
Related articles from newspapers, magazines, journals, and more
